Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3745627016 | Daclizumab only product in parenteral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3745628014 | Product containing only daclizumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only daclizumab in parenteral dose form (medicinal product form) | Is a | Product containing daclizumab in parenteral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only daclizumab in parenteral dose form (medicinal product form) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing only daclizumab in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only daclizumab in parenteral dose form (medicinal product form) | Is a | Daclizumab | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only daclizumab in parenteral dose form (medicinal product form) | Has active ingredient | Daclizumab | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR